Clinical Trials Browser

INDUSTRY × Unspecified Adult Solid Tumor, Protocol Specific × eribulin × Clear all

NCT01418677 2016-05-17

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific